Citations

Mayo Clinic

Clear

1113 citation(s) found for "Zoň, Robin".

Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease
Hill, David , Schwarz, Adam J. , Isaac, Maria , Pani, Luca , Vamvakas, Spiros, Hemmings, Robert , Carrillo, María C. , Yu, Peng , Sun, Jia , Boccardi, Marina , Brewer, James B., Brumfield, Martha A., Cantillon, Marc, Cole, Patricia E., Fox, Nick C. , Frisoni, Giovanni B. , Kelleher, Thomas, Luo, Feng , Novak, Gerald , Maguire, Paul, Meibach, Richard C., Patterson, Patricia, Bain, Lisa J. , Raunig, David , Soares, Holly , Suhy, Joyce, Wang, Huanli , Wolz, Robin, Stephenson, Diane , Boccardi, Marina , Frisoni, Giovanni B. , Beckett, Laurel , Jack, Clifford R. , Maguire, Paul, Sampaio, Cristina , Fox, Nick C

Alzheimer's & Dementia | June 28, 2014 | Volume: 10 | Issue: 4 | Pages: 421

10.1016/j.jalz.2013.07.003 | PMID 24985687 Get It

AbstractBackgroundRegulatory qualification of a biomarker for a defined context of use provides scientifically robust assurances to sponsors and regulators that accelerate appropriate adoption of biomarkers into drug development.MethodsThe Coalition Against Major Diseases submitted a dossier to the Scientific Advice Working Party of the European Medicines Agency requesting a qualification opinion on the use of hippocampal volume as a biomarker for enriching clinical trials in subjects with mild cognitive impairment, incorporating a scientific rationale, a literature review and a de novo analysis of Alzheimer's Disease Neuroimaging Initiative data.ResultsThe literature review and de novo analysis were consistent with the proposed context of use, and the Committee for Medicinal Products for Human Use released an opinion in November 2011.ConclusionsWe summarize the scientific rationale and the data that supported the first qualification of an imaging biomarker by the European Medicines Agency.
The Impact ofStaphylococcus aureus-Associated Molecular Patterns on Staphylococcal Superantigen-Induced Toxic Shock Syndrome and Pneumonia
Tilahun, Ashenafi Y. , Karau, Melissa J. , Ballard, Alessandro D. , Gunaratna, Miluka P. , Thapa, Anusa , David, Chella S., Patel, Robin , Rajagopalan, Govindarajan , Karau, Melissa , Ballard, Alessandro , Patel, Robin

Mediators of Inflammation | June 12, 2014 | Volume: 2014 | Issue: No issue available | Pages: 1-13

10.1155/2014/468285 | PMID 25024509 Get It

Staphylococcus aureusis capable of causing a spectrum of human illnesses. During seriousS. aureusinfections, the staphylococcal pathogen-associated molecular patterns (PAMPs) such as peptidoglycan, lipoteichoic acid, and lipoproteins and even intactS. aureus, are believed to act in conjunction with the staphylococcal superantigens (SSAg) to activate the innate and adaptive immune system, respectively, and cause immunopathology. However, recent studies have shown that staphylococcal PAMPs could suppress inflammation by several mechanisms and protect from staphylococcal toxic shock syndrome, a life-threatening systemic disease caused by toxigenicS. aureus. Given the contradictory pro- and anti-inflammatory roles of staphylococcal PAMPs, we examined the effects ofS. aureus-derived molecular patterns on immune responses driven by SSAgin vivousing HLA-DR3 and HLA-DQ8 transgenic mice. Our study showed that neitherS. aureus-derived peptidoglycans (PGN), lipoteichoic acid (LTA), nor heat-killedStaphylococcus aureus(HKSA) inhibited SSAg-induced T cell proliferationin vitro. They failed to antagonize the immunostimulatory effects of SSAgin vivoas determined by their inability to attenuate systemic cytokine/chemokine response and reduce SSAg-induced T cell expansion. These staphylococcal PAMPs also failed to protect HLA-DR3 as well as HLA-DQ8 transgenic mice from either SSAg-induced toxic shock or pneumonia induced by a SSAg-producing strain ofS. aureus.
Desulfovibrio legallii Prosthetic Shoulder Joint Infection and Review of Antimicrobial Susceptibility and Clinical Characteristics of Desulfovibrio Infections
Vasoo, Shawn , Mason, Erin L., Gustafson, Daniel R., Cunningham, Scott A. , Cole, Nicolynn C., Vetter, Emily A., Steinmann, Scott P. , Wilson, Walter R., Patel, Robin , Berbari, Elie F. , Henry, Nancy K., Patel, Robin , Cunningham, Scott A

Journal of Clinical Microbiology | May 22, 2014 | Volume: 52 | Issue: 8 | Pages: 3105-3110

10.1128/jcm.00083-14 | PMID 24850351 Get It

ABSTRACT We describe a case of shoulder hemiarthroplasty infection with Desulfovibrio legallii . Antimicrobial susceptibilities of 36 Desulfovibrio isolates are presented. Metronidazole and carbapenems exhibited reliable activity, although piperacillin-tazobactam did not. Eleven previous cases of Desulfovibrio infection are reviewed; most arose from a gastrointestinal tract-related source.
Reovirus Activates Human Dendritic Cells to Promote Innate Antitumor Immunity
Errington‐Mais, Fiona , Steele, Lynette P., Prestwich, Robin, Harrington, Kevin J. , Pandha, Hardev , Vidal, Laura , Bono, Johann S. de , Selby, Peter J. , Vile, Richard G. , Melcher, Alan , Coffey, Matt C. , Errington-Mais, Fiona , Melcher, Alan A , Harrington, Kevin , de Bono, Johann

The Journal of Immunology | April 23, 2014 | Volume: 180 | Issue: 9 | Pages: 6018-6026

10.4049/jimmunol.180.9.6018 | PMID 18424722 Get It

Abstract Oncolytic viruses can exert their antitumor activity via direct oncolysis or activation of antitumor immunity. Although reovirus is currently under clinical investigation for the treatment of localized or disseminated cancer, any potential immune contribution to its efficacy has not been addressed. This is the first study to investigate the ability of reovirus to activate human dendritic cells (DC), key regulators of both innate and adaptive immune responses. Reovirus induced DC maturation and stimulated the production of the proinflammatory cytokines IFN-α, TNF-α, IL-12p70, and IL-6. Activation of DC by reovirus was not dependent on viral replication, while cytokine production (but not phenotypic maturation) was inhibited by blockade of PKR and NF-κB signaling. Upon coculture with autologous NK cells, reovirus-activated DC up-regulated IFN-γ production and increased NK cytolytic activity. Moreover, short-term coculture of reovirus-activated DC with autologous T cells also enhanced T cell cytokine secretion (IL-2 and IFN-γ) and induced non-Ag restricted tumor cell killing. These data demonstrate for the first time that reovirus directly activates human DC and that reovirus-activated DC stimulate innate killing by not only NK cells, but also T cells, suggesting a novel potential role for T cells in oncolytic virus-induced local tumor cell death. Hence reovirus recognition by DC may trigger innate effector mechanisms to complement the virus’s direct cytotoxicity, potentially enhancing the efficacy of reovirus as a therapeutic agent.
Inhibition Controls for Qualitative Real-Time PCR Assays: Are They Necessary for All Specimen Matrices?
Buckwalter, Seanne P., Sloan, Lynne M., Cunningham, Scott A. , Espy, Mark J., Uhl, J. R., Jones, Mary F. , Vetter, Emily A., Mandrekar, Jayawant N. , Cockerill, Franklin R., Pritt, Bobbi S. , Patel, Robin , Wengenack, Nancy L. , Patel, Robin , Pritt, Bobbi S , Cunningham, Scott A

Journal of Clinical Microbiology | April 16, 2014 | Volume: 52 | Issue: 6 | Pages: 2139-2143

10.1128/jcm.03389-13 | PMID 24740078 Get It

ABSTRACT A retrospective analysis of 386,706 specimens representing a variety of matrix types used in qualitative real-time PCR assays determined the overall inhibition rate to be 0.87% when the inhibition control was added preextraction to 5,613 specimens and 0.01% when the inhibition control was added postextraction but preamplification in 381,093 specimens. Inhibition rates of ≤1% were found for all specimen matrix types except urine and formalin-fixed, paraffin-embedded tissue.
Streptococcus suis-Related Prosthetic Joint Infection and Streptococcal Toxic Shock-Like Syndrome in a Pig Farmer in the United States
Gomez, Eric, Kennedy, Cassie C. , Cunningham, Scott A. , Patel, Robin , Virk, Abinash, Gottschalk, Marcelo G , Virk, Abinash , Patel, Robin , Kennedy, Cassie C , Cunningham, Scott A

Journal of Clinical Microbiology | April 10, 2014 | Volume: 52 | Issue: 6 | Pages: 2254-2258

10.1128/jcm.02934-13 | PMID 24719433 Get It

ABSTRACT Streptococcus suis is an emerging swine-associated zoonotic agent that can cause meningitis and septicemia in humans. We present, to our knowledge, the first case of S. suis arthroplasty infection and streptococcal toxic shock-like syndrome due to an nonencapsulated serotype 5 strain in North America.
Detection of Prosthetic Joint Infection by Use of PCR-Electrospray Ionization Mass Spectrometry Applied to Synovial Fluid
Melendez, Dante P. , Uhl, James R., Greenwood‐Quaintance, Kerryl E. , Hanssen, Arlen D. , Sampath, Rangarajan , Patel, Robin , Patel, Robin

Journal of Clinical Microbiology | April 10, 2014 | Volume: 52 | Issue: 6 | Pages: 2202-2205

10.1128/jcm.00570-14 | PMID 24719438 Get It

ABSTRACT PCR coupled with electrospray ionization mass spectrometry applied to synovial fluid specimens had an 81% sensitivity and a 95% specificity for the diagnosis of prosthetic joint infection.
Misidentification of Neisseria polysaccharea as Neisseria meningitidis with the Use of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry
Cunningham, Scott A. , Mainella, Jill M., Patel, Robin , Patel, Robin , Cunningham, Scott A

Journal of Clinical Microbiology | April 3, 2014 | Volume: 52 | Issue: 6 | Pages: 2270-2271

10.1128/jcm.00664-14 | PMID 24696027 Get It

Prosthetic Joint Infection
Tande, Aaron J. , Patel, Robin , Tande, Aaron , Patel, Robin

Clinical Microbiology Reviews | April 2, 2014 | Volume: 27 | Issue: 2 | Pages: 302-345

10.1128/cmr.00111-13 | PMID 24696437 Get It

SUMMARY Prosthetic joint infection (PJI) is a tremendous burden for individual patients as well as the global health care industry. While a small minority of joint arthroplasties will become infected, appropriate recognition and management are critical to preserve or restore adequate function and prevent excess morbidity. In this review, we describe the reported risk factors for and clinical manifestations of PJI. We discuss the pathogenesis of PJI and the numerous microorganisms that can cause this devastating infection. The recently proposed consensus definitions of PJI and approaches to accurate diagnosis are reviewed in detail. An overview of the treatment and prevention of this challenging condition is provided.